Department of Health and Human Services January 2022 – Federal Register Recent Federal Regulation Documents

Results 101 - 150 of 333
National Center for Advancing Translational Sciences; Notice of Closed Meeting
Document Number: 2022-01233
Type: Notice
Date: 2022-01-24
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Complementary & Integrative Health; Notice of Closed Meeting
Document Number: 2022-01232
Type: Notice
Date: 2022-01-24
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Complementary & Integrative Health; Notice of Closed Meeting
Document Number: 2022-01231
Type: Notice
Date: 2022-01-24
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2022-01230
Type: Notice
Date: 2022-01-24
Agency: Department of Health and Human Services, National Institutes of Health
Notice of Award of a Single-Source Cooperative Agreement To Fund the Vietnam Department of Animal Health
Document Number: 2022-01274
Type: Notice
Date: 2022-01-24
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $1,000,000, with an expected total funding of approximately $5,000,000 over a five-year project period, to the Vietnam Department of Animal Health. The award will strengthen capabilities and maintain the government run laboratory-supported surveillance at the animal-human interface for avian and non-avian influenza viruses, other zoonotic diseases (e.g., rabies, African Swine Fever, etc.), and other respiratory zoonotic viruses (e.g., SARS-CoV-2) in Vietnam.
Notice of Award of a Single-Source Cooperative Agreement To Fund National Institute for Communicable Diseases (NICD), South Africa
Document Number: 2022-01271
Type: Notice
Date: 2022-01-24
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $5,000,000 for Year 1 of funding to the National Institute for Communicable Diseases (NICD), South Africa. The award will provide accurate, timely, and high-quality strategic information to enable the South African Government (SAG) to track critical infectious disease pathogens, monitor interventions, and inform policy and programming to reduce disease transmission and burden. Annual award amounts for years 2-5 will be set at continuation.
Notice of Award of a Single-Source Cooperative Agreement To Fund the Republican AIDS Center, Kyrgyz Republic
Document Number: 2022-01266
Type: Notice
Date: 2022-01-24
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $2,000,000 for Year 1 of funding to the Republican AIDS Center, Kyrgyz Republic (KR). The award will build on previous President's Emergency Plan for AIDS Relief (PEPFAR) program support to ensure continuity of high-quality HIV services to existing clients across the HIV cascade, the steps of care (from diagnosis to achieving viral load (VL) suppression) for people living with HIV (PLHIV), and achieve the Joint United Nations Programme on HIV/AIDs (UNAIDS) 95-95-95 goals (95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression). Annual award amounts for years 2-5 will be set at continuation.
Privacy Act of 1974; System of Records
Document Number: 2022-01066
Type: Notice
Date: 2022-01-24
Agency: Department of Health and Human Services, Administration for Children and Families
In accordance with the requirements of the Privacy Act of 1974, as amended, the Department of Health and Human Services (HHS) is modifying three systems of records maintained by the Administration for Children and Families (ACF), Office of Child Support Enforcement (OCSE): System Number 09-80-0381, ``OCSE National Directory of New Hires, HHS/ACF/OCSE''; System No. 09-80-0383, ``OCSE Debtor File, HHS/ ACF/OCSE''; and System No. 09-80-0387, ``Federal Parent Locator Service Child Support Services Portal, HHS/ACF/OCSE'' (now renamed ``Child Support Portal Registration Records, HHS/ACF/OCSE'').
Request for Information: Electronic Prior Authorization Standards, Implementation Specifications, and Certification Criteria
Document Number: 2022-01309
Type: Proposed Rule
Date: 2022-01-24
Agency: Department of Health and Human Services, Office of the Secretary
This request for information seeks input from the public regarding electronic prior authorization standards, implementation specifications, and certification criteria that could be adopted within the ONC Health IT Certification Program. Responses to this Request for Information will be used to inform potential future rulemaking.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2022-01183
Type: Notice
Date: 2022-01-21
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Agency Information Collection Activities: Proposed Collection: Public Comment Request; Maternal and Child Health Bureau Performance Measures for Discretionary Grant Information System
Document Number: 2022-01114
Type: Notice
Date: 2022-01-21
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Meeting of the Tick-Borne Disease Working Group
Document Number: 2022-01106
Type: Notice
Date: 2022-01-21
Agency: Department of Health and Human Services
As required by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual meeting. The meeting will be open to the public. For this meeting, the TBDWG will (1) hear presentations from six subcommittees on findings and potential actions from reports prepared for the TBDWG to consider and (2) further discuss plans for developing the next report to the HHS Secretary and Congress on federal tick-borne activities and research, taking into consideration the 2018 and 2020 report. The 2022 report will address a wide range of topics related to tick-borne diseases, such as, surveillance, prevention, diagnosis, diagnostics, and treatment; identify advances made in research, as well as overlap and gaps in tick-borne disease research; and provide recommendations regarding any appropriate changes or improvements to such activities and research.
National Advisory Committee on Children and Disasters
Document Number: 2022-01161
Type: Notice
Date: 2022-01-21
Agency: Department of Health and Human Services
The National Advisory Committee on Children and Disasters (NACCD or the Committee) is required by section 2811A of the PHS Act as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) and governed by the provisions of the Federal Advisory Committee Act (FACA). The NACCD shall evaluate issues and programs and provide findings, advice, and recommendations to the Secretary of HHS to support and enhance all-hazards public health and medical preparedness, response, and recovery aimed at meeting the unique needs of children and their families across the entire spectrum of their wellbeing. The Secretary of HHS has formally delegated authority to operate the NACCD to ASPR.
Medical Devices; Immunology and Microbiology Devices; Classification of Human Leukocyte, Neutrophil and Platelet Antigen and Antibody Tests
Document Number: 2022-01156
Type: Proposed Rule
Date: 2022-01-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) is proposing to classify Human Leukocyte Antigen (HLA), Human Platelet Antigen (HPA), and Human Neutrophil Antigen (HNA) devices, a generic type of device, into class II (special controls). FDA is identifying proposed special controls for HLA, HPA, and HNA devices that are necessary to provide a reasonable assurance of safety and effectiveness. FDA is also giving notice that we do not intend to exempt these device types from premarket notification requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act). FDA is publishing in this document the recommendations of the Blood Products Advisory Committee, serving as a device classification panel, regarding the classification of these devices. After considering public comments on the proposed classification, FDA will publish a final regulation classifying these device types.
Medical Devices; Ophthalmic Devices; Classification of the Retinal Diagnostic Software Device
Document Number: 2022-01147
Type: Rule
Date: 2022-01-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is classifying the retinal diagnostic software device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the retinal diagnostic software device's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices.
Guidance Documents Related to Coronavirus Disease 2019; Availability
Document Number: 2022-01146
Type: Notice
Date: 2022-01-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of FDA guidance documents related to the Coronavirus Disease 2019 (COVID-19) public health emergency (PHE). This notice of availability (NOA) is pursuant to the process that FDA announced, in the Federal Register of March 25, 2020, for making available to the public COVID-19-related guidances. The guidances identified in this notice address issues related to the COVID-19 PHE and have been issued in accordance with the process announced in the March 25, 2020, notice. The guidances have been implemented without prior comment, but they remain subject to comment in accordance with the Agency's good guidance practices.
Collecting and Providing 702(b) Portions of Food and Drug Administration Official Samples-Questions and Answers; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
Document Number: 2022-01143
Type: Notice
Date: 2022-01-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing the availability of a draft guidance for industry and FDA staff entitled ``Collecting and Providing 702(b) Portions of FDA Official Samples Questions and Answers.'' This draft guidance is intended to assist industry and FDA staff with issues and questions related to the requirements for FDA to collect and provide a part of an official sample of an article to any person named on the label of the article, or the owner thereof, or his attorney or agent.
Revocation of Five Authorizations of Emergency Use of In Vitro Diagnostic Devices for Detection and/or Diagnosis of COVID-19; Availability
Document Number: 2022-01139
Type: Notice
Date: 2022-01-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorizations (EUAs) (the Authorizations) issued to Cellex Inc. for the Cellex q-SARS-CoV-2 IgG/ IgM Rapid Test, BioM[eacute]rieux SA for the SARS-COV-2 R-GENE, Siemens Healthcare Diagnostics Inc. for the Atellica IM SARS-CoV-2 IgG (COV2G), Siemens Healthcare Diagnostics Inc. for the ADVIA Centaur SARS-CoV-2 IgG (COV2G), and Cepheid for the Xpert Omni SARS-CoV-2. FDA revoked these Authorizations under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocations, which include an explanation of the reasons for each revocation, are reprinted in this document.
Annual Update of the HHS Poverty Guidelines
Document Number: 2022-01166
Type: Notice
Date: 2022-01-21
Agency: Department of Health and Human Services, Office of the Secretary
This notice provides an update of the Department of Health and Human Services (HHS) poverty guidelines to account for last calendar year's increase in prices as measured by the Consumer Price Index.
Meeting of the National Vaccine Advisory Committee
Document Number: 2022-01101
Type: Notice
Date: 2022-01-21
Agency: Department of Health and Human Services
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a virtual meeting. The meeting will be open to the public and public comment will be heard during the meeting.
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2022-01028
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings
Document Number: 2022-01027
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting
Document Number: 2022-01026
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Closed Meeting
Document Number: 2022-01029
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Document Number: 2022-01084
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting
Document Number: 2022-01083
Type: Notice
Date: 2022-01-20
Agency: Department of Health and Human Services, National Institutes of Health
Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2022-00937
Type: Notice
Date: 2022-01-19
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance \1\ related to the ``generic'' clearance process. Generally, this is an expedited process by which agencies may obtain OMB's approval of collection of information requests that are ``usually voluntary, low-burden, and uncontroversial collections,'' do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. On October 23, 2011, OMB approved our initial request to use the generic clearance process under control number 0938-1148 (CMS-10398). It was last approved on April 26, 2021, via the standard PRA process which included the publication of 60- and 30-day Federal Register notices. The scope of the April 2021 umbrella accounts for Medicaid and CHIP State plan amendments, waivers, demonstrations, and reporting. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: The necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings
Document Number: 2022-00963
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2022-00962
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
Submission for OMB Review; Child Support Annual Data Report (OCSE-157) (OMB No.: 0970-0177)
Document Number: 2022-00917
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Administration for Children and Families
The Office of Child Support Enforcement (OCSE), Administration for Children and Families (ACF), is requesting approval of a 3-year extension of the Child Support Annual Data Report and Instructions (OCSE-157). The current Office of Management and Budget (OMB) approval expires on March 31, 2022. OCSE made minor revisions to the form's instructions.
Notice of Publication of the Trusted Exchange Framework and Common Agreement
Document Number: 2022-00948
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Office of the Secretary
This notice fulfills an obligation under the Public Health Service Act (PHSA), which requires the National Coordinator for Health Information Technology to publish on the Office of the National Coordinator for Health Information Technology's public internet website, and in the Federal Register, the trusted exchange framework and common agreement developed under the PHSA.
Patient Safety Organizations: Voluntary Relinquishment for the Theator, Inc. PSO
Document Number: 2022-00906
Type: Notice
Date: 2022-01-19
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to list as a patient safety organization (PSO) an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ``delisted'' by the Secretary if it is found to no longer meet the requirements of the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO's listing expires. AHRQ accepted a notification of proposed voluntary relinquishment from the Theator, Inc. PSO, PSO number P0218, of its status as a PSO, and has delisted the PSO accordingly.
Clinical Laboratory Improvement Amendments of 1988 (CLIA) Proficiency Testing Regulations Related to Analytes and Acceptable Performance; Extension of Timeline for Publication of Final Rule
Document Number: 2022-00932
Type: Proposed Rule
Date: 2022-01-19
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Social Security Act (the Act) specifies that a Medicare final rule must be published no later than 3 years after the publication date of the proposed rule or interim final rule, as applicable, except under exceptional circumstances. In accordance with the Act, this document announces an extension of the timeline for publication of the final rule and includes a brief explanation of the justification for the variation.
Draft Policy Statement for Biosafety Level 4 (BSL-4) and Animal BSL-4 (ABSL-4) Laboratory Verification; Notice of Availability
Document Number: 2022-00928
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on a draft policy statement regarding Biosafety Level 4 (BSL-4)/Animal Biosafety Level 4 (ABSL-4) verification requirements. The policy statement, once finalized, will assist individuals and entities in verifying that the facility design parameters and operational procedures, including heating, ventilation, and air conditioning (HVAC) systems, in BSL-4 and/or ABLS-4 laboratories are functioning as intended to meet the biosafety sufficiency requirement in the HHS/CDC select agent regulations.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2022-00856
Type: Notice
Date: 2022-01-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2022-00855
Type: Notice
Date: 2022-01-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of Closed Meeting
Document Number: 2022-00868
Type: Notice
Date: 2022-01-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of Closed Meeting
Document Number: 2022-00867
Type: Notice
Date: 2022-01-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Agency Information Collection Activities; Proposed Collection; Comment Request; Prevention of Salmonella Enteritidis in Shell Eggs During Production; Recordkeeping and Registration Provisions
Document Number: 2022-00863
Type: Notice
Date: 2022-01-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's recordkeeping and registration requirements for shell egg producers.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2022-00861
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2022-00860
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2022-00858
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2022-00857
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: 2022-00901
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
National Human Genome Research Institute; Notice of Closed Meeting
Document Number: 2022-00900
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: 2022-00899
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Minority Health and Health Disparities; Notice of Closed Meetings
Document Number: 2022-00898
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2022-00897
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, National Institutes of Health
Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children
Document Number: 2022-00896
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services, Health Resources and Services Administration
In accordance with the Public Health Service Act and the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC or Committee) has scheduled a public meeting to be held on Thursday, February 10, 2022, and Friday, February 11, 2022. Information about the ACHDNC and the agenda for this meeting can be found on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable- disorders/.
Agency Information Collection Activities; Submission for OMB Review; Centers for Independent Living Program Performance Report (CIL PPR) (0985-0061)
Document Number: 2022-00892
Type: Notice
Date: 2022-01-19
Agency: Department of Health and Human Services
The Administration for Community Living (ACL) is announcing that the proposed collection of information listed above has been submitted to the Office of Management and Budget (OMB) for review and clearance as required under section 506(c)(2)(A) of the Paperwork Reduction Act of 1995. This 30-Day notice collects comments on the information collection requirements related to Centers for Independent Living Program Performance Report (CIL PPR) (0985-0061).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.